Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US JP Boyle, AA Honeycutt, KMV Narayan, TJ Hoerger, LS Geiss, H Chen, ... Diabetes care 24 (11), 1936-1940, 2001 | 1231 | 2001 |
Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003. A Honeycutt, L Dunlap, H Chen, G Homsi, S Grosse, D Schendel MMWR: Morbidity & Mortality Weekly Report 53 (3), 2004 | 721* | 2004 |
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050 JB Saaddine, AA Honeycutt, KMV Narayan, X Zhang, R Klein, JP Boyle Archives of ophthalmology 126 (12), 1740-1747, 2008 | 485 | 2008 |
Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments DB Rein, JS Wittenborn, X Zhang, AA Honeycutt, SB Lesesne, J Saaddine, ... Archives of ophthalmology 127 (4), 533-540, 2009 | 428 | 2009 |
Medical costs of CKD in the Medicare population AA Honeycutt, JE Segel, X Zhuo, TJ Hoerger, K Imai, D Williams Journal of the American Society of Nephrology 24 (9), 1478-1483, 2013 | 293 | 2013 |
Outcomes and costs of community health worker interventions: a systematic review M Viswanathan, JL Kraschnewski, B Nishikawa, LC Morgan, ... Medical care 48 (9), 792-808, 2010 | 288 | 2010 |
Outcomes of community health worker interventions. M Viswanathan, J Kraschnewski, B Nishikawa, LC Morgan, P Thieda, ... Evidence report/technology assessment, 1-144, A1, 2009 | 278 | 2009 |
A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050 AA Honeycutt, JP Boyle, KR Broglio, TJ Thompson, TJ Hoerger, LS Geiss, ... Health care management science 6, 155-164, 2003 | 159 | 2003 |
Technology-enhanced program for child disruptive behavior disorders: Development and pilot randomized control trial DJ Jones, R Forehand, J Cuellar, J Parent, A Honeycutt, O Khavjou, ... Journal of Clinical Child & Adolescent Psychology 43 (1), 88-101, 2014 | 138 | 2014 |
Global economic impact of multiple sclerosis M Trisolini, A Honeycutt, J Wiener, S Lesesne Multiple Sclerosis International Federation, 2010 | 100 | 2010 |
Comparing cost‐of‐illness estimates from alternative approaches: an application to diabetes AA Honeycutt, JE Segel, TJ Hoerger, EA Finkelstein Health services research 44 (1), 303-320, 2009 | 77 | 2009 |
A linear programming model for allocating HIV prevention funds with state agencies: a pilot study SR Earnshaw, K Hicks, A Richter, A Honeycutt Health Care Management Science 10 (3), 239-252, 2007 | 74 | 2007 |
Management of bronchiolitis in infants and children. M Viswanathan, VJ King, C Bordley, AA Honeycutt, J Wittenborn, ... Evidence report/technology assessment (Summary), 1-5, 2003 | 66 | 2003 |
Incorporating mobile phone technologies to expand evidence-based care DJ Jones, M Anton, M Gonzalez, A Honeycutt, O Khavjou, R Forehand, ... Cognitive and behavioral practice 22 (3), 281-290, 2015 | 49 | 2015 |
Economic costs attributable to diabetes in each US state SS Shrestha, AA Honeycutt, W Yang, P Zhang, OA Khavjou, DC Poehler, ... Diabetes Care 41 (12), 2526-2534, 2018 | 48 | 2018 |
Contribution of anal sex to HIV prevalence among heterosexuals: a modeling analysis A O’leary, E DiNenno, A Honeycutt, B Allaire, S Neuwahl, K Hicks, ... AIDS and Behavior 21, 2895-2903, 2017 | 45 | 2017 |
Vision Health Cost-Effectiveness Study Group Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments DB Rein, JS Wittenborn, X Zhang, AA Honeycutt, SB Lesesne, J Saaddine Arch Ophthalmol 127 (533), e540, 2009 | 42 | 2009 |
Outcomes of community health worker interventions: evidence report/technology assessment no. 181 (Prepared by the RTI International-University of North Carolina Evidence-based … M Viswanathan, J Kraschnewski, B Nishikawa, LC Morgan, P Thieda, ... Agency for Healthcare Research and Quality, 2009 | 40 | 2009 |
Cost-effectiveness of sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: results of the ROSETTA randomized trial HS Harvie, CL Amundsen, SJ Neuwahl, AA Honeycutt, ES Lukacz, ... The Journal of urology 203 (5), 969-977, 2020 | 38 | 2020 |
Community-based interventions to decrease obesity and tobacco exposure and reduce health care costs: outcome estimates from communities putting prevention to work for 2010–2020 R Soler, D Orenstein, A Honeycutt, C Bradley, J Trogdon, CK Kent, K Wile, ... Preventing Chronic Disease 13, 2016 | 37 | 2016 |